Home/ Supplements/ Melatonin/ NutraSpray Melatonin 1.5 mg Orange Flavo...

NutraSpray Melatonin 1.5 mg Orange Flavor

product on market Liquid Source Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Melatonin is supported by strong evidence for reducing sleep onset latency, while Vitamin B6 serves as a cofactor in the synthesis of neurotransmitters. Research indicates these ingredients may help regulate sleep-wake cycles and support neurological function. The overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for NutraSpray Melatonin 1.5 mg Orange Flavor
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Spray(s)
Serving Size
Other Combinations
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1.5 mg (80% DV)
1.2× RDA — within safe limits 114 studies (A:3, B:35)
1.5 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

purified Water Vegetable Glycerine natural Orange flavor Soy Lecithin Lauric Arginate Potassium Benzoate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: 1 to 3 sprays before bedtime. Each spray delivers approx. 1.5 mg of melatonin. Spray liquid in the mouth, allow to remain for 30 seconds and swish before swallowing.

Shake well before using.

Warnings & Precautions

Do not use if tamper-evident seal is broken or missing.

Keep out of the reach of children.

Do not take more than 3 full sprays unless recommended by your physician.

Warning: Use only at bedtime. For adult use only.

Not for use by children, teenagers, or women who are pregnant, may become pregnant, or breastfeeding.

Not for use by children, teenagers, or women who are pregnant, may become pregnant, or breastfeeding. If you are under medical supervision, or have an autoimmune disease, diabetes, a depressive disorder, a thyroid condition, epilepsy, leukemia, or a lymphoproliferative disorder, or are taking MAO inhibitor drugs or corticosteroids such as hydrocortisone or prednisone, consult your physician before using this product.

If you are under medical supervision, or have an autoimmune disease, diabetes, a depressive disorder, a thyroid condition, epilepsy, leukemia, or a lymphoproliferative disorder, or are taking MAO inhibitor drugs or corticosteroids such as hydrocortisone or prednisone, consult your physician before using this product. Do not take with alcoholic beverages or when operating machinery or driving a vehicle.

Additional Information

SN0328 REV B172-A

New look

Metadata

Product Details

UPC / SKU0 21078 00328 1
DSLD Entry Date2017-04-25
Product TypeOther Combinations
FormLiquid
DSLD ID72532
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.